Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Real-world data analysis reveals GLP-1 drugs can protect kidneys and hearts in diabetic patients but also introduce surprising new health risks. Study: Real-world comparative outcomes of GLP-1 RA ...

Now used for type 2 diabetes, new study shows GLP-1 drugs helped people with type 1 keep blood glucose levels in a healthy range while also losing weight. Skip to Main Content.

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

GLP-1 drugs like Ozempic® and Zepbound® have gained significant attention for treating both diabetes and assisting with weight loss.

See how GLP-1 drugs reduce heart and kidney complications in MGUS and diabetes—explore the clinical evidence. Keep reading!

A study published in the Journal of Medical Toxicology by researchers at the University of Alabama at Birmingham found that ...

An Ozempic user has revealed one unexpected side effect that's 'causing issues in their relationship'. While many people are having a lot of success taking GLP-1 drugs such as Ozempic, Mounjaro and ...

The Delhi High Court on Wednesday directed the Central Drugs Standard Control Organisation (CDSCO) to decide, within 3 month ...

Investigators examined the comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in a real-world setting.

Remarkable new findings about the sugar stores in neurons have unlocked an entire new method of treating Alzheimer's disease ...